Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

AstraZeneca Plc Enhertu trial hits key PFS goal

The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...

April 22, 2025

HUTCHMED completes Savolitinib trial enrollment

HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...

April 22, 2025

Spine care surge positions One Health for investor growth

Discover One Health Group's innovative approach to back and spine care, blending advanced surgeries with non-invasive therapies for optimal patient outcomes...

April 17, 2025

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

April 17, 2025

Breakthrough blood test set to transform testicular cancer detection

A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...

April 16, 2025

Discover how FluCamp is shaping the future of medical breakthroughs

Discover how FluCamp pioneers clinical trials, bridging lab discoveries and revolutionary treatments, ensuring safety and efficacy in modern medicine...

April 14, 2025

Cizzle Biotechnology launches its new corporate website

Cizzle Biotechnology Holdings plc has launched a new corporate website, enhancing access to vital information about its early cancer tests and growth strategy...

April 14, 2025

EDX Medical plc Game-Changing Blood Test Targets Early Detection of Testicular Cancer (Video)

Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..

April 14, 2025

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...

April 14, 2025

Poolbeg Pharma’s strategic move into a $10 billion oncology market

Poolbeg Pharma is innovating in oncology with POLB 001, a promising p38 MAP kinase inhibitor targeting Cytokine Release Syndrome, a critical complication in cancer therapies...

April 11, 2025

LPC joins forces with One Health Group to launch first surgical hub

One Health Group is set to transform orthopaedic care in the North of England with its first surgical hub, enhancing patient access to essential NHS services...

April 11, 2025

EDX Medical Group to launch highly accurate early detection test for testicular cancer

EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...

April 11, 2025

Optima Health expands into Ireland with Cognate Health acquisition

Optima Health Plc has announced its acquisition of Cognate Health Limited for up to €9 million, expanding its footprint in the Irish occupational health sector...

April 11, 2025

A powerful push for prostate cancer awareness

Bishop David Walker's prostate cancer diagnosis highlights the importance of early detection and proactive healthcare, urging men to get tested before symptoms arise...

April 10, 2025

hVIVO delivers record 2024 results, revenue up 11.9% and EBITDA up 25.9%

hVIVO plc reports impressive audited results for 2024, showcasing a revenue increase and strong EBITDA growth in the human challenge clinical trial sector...

April 10, 2025

Nuformix reports positive NXP002 results in lung disease models

Nuformix plc announces promising re-analysis results for NXP002, targeting unmet needs in fibrosis and oncology, offering insights into new treatment pathways...

April 9, 2025

Unlocking growth through untapped talent at One Health Group

Under CEO Adam Binns, One Health Group has revolutionized healthcare through innovation, talent development, and strategic growth, achieving remarkable financial success...

April 8, 2025

AstraZeneca Plc Enhertu approved in the EU for HER2 breast cancer

AstraZeneca and Daiichi Sankyo's Enhertu gains EU approval for treating HR-positive, HER2-low metastatic breast cancer, offering new hope for patients...

April 4, 2025

AstraZeneca’s Imfinzi granted FDA approval in the US for bladder cancer

AstraZeneca's Imfinzi has received FDA approval as a groundbreaking treatment for muscle-invasive bladder cancer, significantly improving patient outcomes in clinical trials...

March 31, 2025

GSK Plc Nucala application for COPD accepted by EMA

GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million patients battling this condition...

March 24, 2025

News and Interview Alerts

Company Presentations

Path Acquisition of DG Innovate Presentation

JPMorgan European Discovery Trust, JEDT overview, investments & returns

JPM Multi-Asset Growth & Income plc investor presentation (LON: MATE)

Randall & Quilter Chairman’s overview – rising profitability, growth catalysts, dividends and five year plan

Q&As

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

TEAM plc Mark Clubb Executive Chairman Sets Sights on £2 billion as UCITS Launch Fuels Global Growth

ICG Enterprise Trust: Inside the Numbers Driving Outperformance in Private Equity (Video)

BrokerTalk

CyanConnode: A Stronger Foundation and Growing Momentum – Highlights Panmure Liberum

23 July 2025

Synectics Maintains Strong Momentum with Promising FY25 Outlook – Shore Capital

22 July 2025

Pharos Energy Reaffirms Production Guidance and Strengthens Balance Sheet – Shore Capital

21 July 2025

Touchstone Exploration Sees Production and Pricing Gains from Central Block – Cavendish

21 July 2025

Funds

CQS Natural Resources Growth & Income plc

CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025

22 January 2026

RECI reports strong longer-term NAV performance to December 2025

20 January 2026

Oil’s slide creates opening as market sentiment shifts | Ruffer Investment Company

16 January 2026

How FCSS is harnessing China’s innovation – Kepler Research

15 January 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges

22 January 2026

Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market

22 January 2026

Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside

22 January 2026

Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside

22 January 2026

Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors

22 January 2026

SXX

AstraZeneca Plc Enhertu trial hits key PFS goal

The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...

April 22, 2025

HUTCHMED completes Savolitinib trial enrollment

HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...

April 22, 2025

Spine care surge positions One Health for investor growth

Discover One Health Group's innovative approach to back and spine care, blending advanced surgeries with non-invasive therapies for optimal patient outcomes...

April 17, 2025

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

April 17, 2025

Breakthrough blood test set to transform testicular cancer detection

A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...

April 16, 2025

Discover how FluCamp is shaping the future of medical breakthroughs

Discover how FluCamp pioneers clinical trials, bridging lab discoveries and revolutionary treatments, ensuring safety and efficacy in modern medicine...

April 14, 2025

Cizzle Biotechnology launches its new corporate website

Cizzle Biotechnology Holdings plc has launched a new corporate website, enhancing access to vital information about its early cancer tests and growth strategy...

April 14, 2025

EDX Medical plc Game-Changing Blood Test Targets Early Detection of Testicular Cancer (Video)

Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..

April 14, 2025

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...

April 14, 2025

Poolbeg Pharma’s strategic move into a $10 billion oncology market

Poolbeg Pharma is innovating in oncology with POLB 001, a promising p38 MAP kinase inhibitor targeting Cytokine Release Syndrome, a critical complication in cancer therapies...

April 11, 2025

LPC joins forces with One Health Group to launch first surgical hub

One Health Group is set to transform orthopaedic care in the North of England with its first surgical hub, enhancing patient access to essential NHS services...

April 11, 2025

EDX Medical Group to launch highly accurate early detection test for testicular cancer

EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...

April 11, 2025

Optima Health expands into Ireland with Cognate Health acquisition

Optima Health Plc has announced its acquisition of Cognate Health Limited for up to €9 million, expanding its footprint in the Irish occupational health sector...

April 11, 2025

A powerful push for prostate cancer awareness

Bishop David Walker's prostate cancer diagnosis highlights the importance of early detection and proactive healthcare, urging men to get tested before symptoms arise...

April 10, 2025

hVIVO delivers record 2024 results, revenue up 11.9% and EBITDA up 25.9%

hVIVO plc reports impressive audited results for 2024, showcasing a revenue increase and strong EBITDA growth in the human challenge clinical trial sector...

April 10, 2025

Nuformix reports positive NXP002 results in lung disease models

Nuformix plc announces promising re-analysis results for NXP002, targeting unmet needs in fibrosis and oncology, offering insights into new treatment pathways...

April 9, 2025

Unlocking growth through untapped talent at One Health Group

Under CEO Adam Binns, One Health Group has revolutionized healthcare through innovation, talent development, and strategic growth, achieving remarkable financial success...

April 8, 2025

AstraZeneca Plc Enhertu approved in the EU for HER2 breast cancer

AstraZeneca and Daiichi Sankyo's Enhertu gains EU approval for treating HR-positive, HER2-low metastatic breast cancer, offering new hope for patients...

April 4, 2025

AstraZeneca’s Imfinzi granted FDA approval in the US for bladder cancer

AstraZeneca's Imfinzi has received FDA approval as a groundbreaking treatment for muscle-invasive bladder cancer, significantly improving patient outcomes in clinical trials...

March 31, 2025

GSK Plc Nucala application for COPD accepted by EMA

GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million patients battling this condition...

March 24, 2025